RE:Where does DermTech come in? In my opinion this is just insanely valued.It is currently trading at a market capitalization of $1.26 Billion USD. It latest quarter they lost $.50 cents a share. I know the dermatological community is upset with their outlandish claims. It sound good but to use the strips correctly requires a patient to thoroughly clean the area to be tested, then they need to scrape the suspicious mole or lesion and use a number of test strips to collect the sample. There is lots of opportunity for patient error with this method. The cost is around $500 per mole in Canada. I spoke to a Dermatologist who has had a box of stipsfor over a year and nobody wants the test they would rather be biopsied for accuracy.
So it has a very limited market place like a very sensitive area on the face where you do not want a scar to be present. They are burning $9 million a quarter and have a year's supply of cash left. I think if the market ever turns these are the kinds of shares that get crushed. I think it is a very high risk investment. That is just my opinion.